Extendicare Inc. (LON:0S9E)
United Kingdom · Delayed Price · Currency is GBP · Price in CAD | Market Cap | 1.42B +94.0% |
| Revenue (ttm) | 1.15B +36.2% |
| Net Income | 69.69M +44.3% |
| EPS | 0.73 +30.9% |
| Shares Out | n/a |
| PE Ratio | 20.46 |
| Forward PE | 17.28 |
| Dividend | 0.28 (1.88%) |
| Ex-Dividend Date | Oct 30, 2026 |
| Volume | 9 |
| Open | 28.25 |
| Previous Close | 28.18 |
| Day's Range | 28.25 - 28.25 |
| 52-Week Range | 19.85 - 39.00 |
| Beta | 1.08 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 5, 2026 |
About Extendicare
Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. It operates through the Long-term Care, Home Health Care, and Managed Services segments. The company offers long-term care services, such as accommodation and meals, and assistance with activities of daily living and continuing care to residents; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties and ... [Read more]
Financial Performance
In 2025, Extendicare's revenue was 1.66 billion, an increase of 13.25% compared to the previous year's 1.47 billion. Earnings were 96.66 million, an increase of 28.52%.
Financial numbers in CAD Financial StatementsNews
What Extendicare (EXE) Said on Its Q3 Earnings Call
Extendicare TSE: EXE reported a 41% increase in third-quarter adjusted EBITDA as its CBI acquisition and organic growth in home healthcare boosted results, while executives said they remain open to fu...
What Extendicare (EXE) Said on Its Q3 Earnings Call
Extendicare (TSE:EXE) reported a 41% increase in third-quarter adjusted EBITDA as its CBI acquisition and organic growth in home healthcare boosted results, while executives said they remain open to f...
Extendicare Earnings Call Transcript: Q3 2026
Q3 adjusted EBITDA rose 41% YoY, supported by CBI and organic home health growth. Strong liquidity and 2.3x leverage provide flexibility for M&A and redevelopment, while construction costs and funding timing remain key uncertainties.
Extendicare Earnings release: Q3 2026
Extendicare released its Q3 2026 earnings on November 6, 2026, summarizing the period's financial results.
Extendicare Report: Q3 2026
Extendicare published a report on November 6, 2026 containing material business information for investors and shareholders.
Extendicare MD&A: Q3 2026
Extendicare filed a regulatory document on November 6, 2026 disclosing important business information.
Extendicare Slides: Q3 2026
Extendicare has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on November 6, 2026.
Extendicare Inc Announces Climb In Q3 Profit
(RTTNews) - Extendicare Inc (EXEA) reported a profit for its third quarter that Increases, from last year
Extendicare Announces 2026 Third Quarter Results
Markham, Ontario--(Newsfile Corp. - November 5, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") today reported results for the three and nine months ended September 30, 2026. Thir...
Extendicare price target raised to C$40 from C$38 at CIBC
CIBC raised the firm’s price target on Extendicare (EXETF) to C$40 from C$38 and keeps an Outperformer rating on the shares.
Extendicare Announces October 2026 Dividend of C$0.0441 per Share
Markham, Ontario--(Newsfile Corp. - October 15, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") announced that it has declared a cash dividend of C$0.0441 per common share of the ...
Extendicare Announces Timing of 2026 Third Quarter Results and Conference Call
Markham, Ontario--(Newsfile Corp. - October 5, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") announced today that it plans to release its financial results for the third quarter...
Extendicare Announces September 2026 Dividend of C$0.0441 per Share
Markham, Ontario--(Newsfile Corp. - September 15, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") announced that it has declared a cash dividend of C$0.0441 per common share of th...
Extendicare Slides: Investor presentation
Extendicare has posted slides in relation to its latest quarterly earnings report, which was published on September 9, 2026.
“Make a real offer, or pick an arbitrator” - CUPE holds province-wide day of action to call out delays in negotiations with Extendicare
Markham, ON--(BUSINESS WIRE)--For months, 8 CUPE locals representing over 1100 Long-Term Care workers across Ontario have been kept waiting for a fair contract. Where other workers would have been abl...
Care Can't Wait! Long-Term Care workers hold province wide day of action calling out delays in contract negotiations with Extendicare
OTTAWA--(BUSINESS WIRE)--For months, 8 CUPE locals representing over 1100 long term care workers across Ontario have been kept waiting for a fair contract. Where other workers would have been able to ...
CUPE members take action to demand a fair deal from Extendicare
Sudbury, ON--(BUSINESS WIRE)--CUPE 1182, one of 8 CUPE locals participating in the Extendicare Central Table bargaining held a rally in Sudbury today. The union representing workers at Extendicare Yor...
Extendicare price target raised to C$39 from C$38 at RBC Capital
RBC Capital raised the firm’s price target on Extendicare (EXETF) to C$39 from C$38 and keeps an Outperform rating on the shares.
Extendicare price target raised to C$40 from C$38 at CIBC
CIBC raised the firm’s price target on Extendicare (EXETF) to C$40 from C$38 and keeps an Outperformer rating on the shares.
Extendicare Earnings Call Transcript: Q2 2026
Q2 2026 saw revenue surge 59.4% and adjusted EBITDA rise 71%, driven by major acquisitions and robust organic growth. Home health care volumes more than doubled, while new capital structure improved leverage and flexibility. Integration of recent acquisitions is progressing, with synergy targets on track.
Extendicare Earnings release: Q2 2026
Extendicare released its Q2 2026 earnings on August 7, 2026, summarizing the period's financial results.
Extendicare MD&A: Q2 2026
Extendicare filed a regulatory document on August 7, 2026 disclosing important business information.
Extendicare Report: Q2 2026
Extendicare published a report on August 7, 2026 containing material business information for investors and shareholders.
Extendicare Slides: Q2 2026
Extendicare has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 7, 2026.
Extendicare Announces Timing of 2026 Second Quarter Results and Conference Call
Markham, Ontario--(Newsfile Corp. - July 7, 2026) - Extendicare Inc. (TSX: EXE) ("Extendicare" or the "Company") announced today that it plans to release its financial results for the second quarter o...